Godbersen, G., Klug, S., Wadsak, W., Pichler, V., Raitanen, J., Rieckmann, A., Stiernman, L., Cocchi, L., Breakspear, M., Hacker, M., Lanzenberger, R., & Hahn, A. (2022). Task-positive networks differentially shape glucose metabolism of the posteromedial default mode network as revealed by [18F]FDG-PET/MR imaging. Neuroscience Applied, 1(Suppl.2), [100684]. https://doi.org/10.1016/j.nsa.2022.100684

Ozenil, M., Skos, L., Roller, A., Gajic, N., Holzer, W., Spreitzer, H., Platzer-Ozenil, S., Vraka, C., Hacker, M., Wadsak, W., & Pichler, V. (2021). Unexpected scaffold rearrangement product of pirenzepine found in commercial samples. Scientific Reports, 11(1), [23397]. https://doi.org/10.1038/s41598-021-02732-y

Calabretta, R., Staber, P. B., Kornauth, C., Lu, X., Binder, P., Pichler, V., Mitterhauser, M., Haug, A., Li, X., & Hacker, M. (2021). Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology, 10(11), [1206]. https://doi.org/10.3390/biology10111206

Hahn, A., Reed, M. B., Pichler, V., Michenthaler, P., Rischka, L., Godbersen, G. M., Wadsak, W., Hacker, M., & Lanzenberger, R. (2021). Functional dynamics of dopamine synthesis during monetary reward and punishment processing. Journal of Cerebral Blood Flow and Metabolism, 41(11), 2973-2985. https://doi.org/10.1177/0271678X211019827

Kranz, G. S., Spies, M., Vraka, C., Kaufmann, U., Klebermass, E. M., Handschuh, P. A., Ozenil, M., Murgaš, M., Pichler, V., Rischka, L., Nics, L., Konadu, M. E., Ibeschitz, H., Traub-Weidinger, T., Wadsak, W., Hahn, A., Hacker, M., & Lanzenberger, R. (2021). High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary report. Psychoneuroendocrinology, 133, [105381]. https://doi.org/10.1016/j.psyneuen.2021.105381

Rischka, L., Godbersen, G. M., Pichler, V., Michenthaler, P., Klug, S., Klöbl, M., Ritter, V., Wadsak, W., Hacker, M., Kasper, S., Lanzenberger, R., & Hahn, A. (2021). Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging. Journal of Cerebral Blood Flow and Metabolism, 41(11), 2986-2999. https://doi.org/10.1177/0271678X211020589

Luurtsema, G., Pichler, V., Bongarzone, S., Seimbille, Y., Elsinga, P., Gee, A., & Vercouillie, J. (2021). EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality. EJNMMI Radiopharmacy and Chemistry, 6(1), [34]. https://doi.org/10.1186/s41181-021-00149-6

Klebermass, E-M., Mahmudi, M., Geist, B. K., Pichler, V., Vraka, C., Balber, T., Miller, A., Haschemi, A., Viernstein, H., Rohr-Udilova, N., Hacker, M., & Mitterhauser, M. (2021). If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[18F]FDG Metabolism. Pharmaceuticals, 14(9), [910]. https://doi.org/10.3390/ph14090910

Ozenil, M., Aronow, J., Millard, M., Langer, T., Wadsak, W., Hacker, M., & Pichler, V. (2021). Update on PET Tracer Development for Muscarinic Acetylcholine Receptors. Pharmaceuticals, 14(6), [530]. https://doi.org/10.3390/ph14060530

Zisser, L., Kulterer, O. C., Itariu, B., Fueger, B., Weber, M., Mazal, P., Vraka, C., Pichler, V., Kautzky-Willer, A., Hacker, M., Karanikas, G., & Rasul, S. (2021). Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing's Syndrome. Anticancer Research, 41(5), 2477-2484. https://doi.org/10.21873/anticanres.15024

Rasul, S., Hartenbach, M., Wollenweber, T., Kretschmer-Chott, E., Grubmüller, B., Kramer, G., Shariat, S., Wadsak, W., Mitterhauser, M., Pichler, V., Vraka, C., Hacker, M., & Haug, A. R. (2021). Prediction of response and survival after standardized treatment with 7400 MBq ¹⁷⁷Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48(5), 1650–1657. https://doi.org/10.1007/s00259-020-05082-5

Bauer, M., Barna, S., Blaickner, M., Prosenz, K., Bamminger, K., Pichler, V., Tournier, N., Hacker, M., Zeitlinger, M., Karanikas, G., & Langer, O. (2021). Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [¹¹C]Metoclopramide. Molecular Imaging and Biology, 23, 180-185. https://doi.org/10.1007/s11307-021-01582-4

Bauer, M., Bamminger, K., Pichler, V., Weber, M., Binder, S., Maier-Salamon, A., Tahir, A., Jäger, W., Haslacher, H., Tournier, N., Hacker, M., Zeitlinger, M., & Langer, O. (2021). Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clinical Pharmacology and Therapeutics, 109(3), 754-761. https://doi.org/10.1002/cpt.2052

Mayerhoefer, M. E., Raderer, M., Lamm, W., Pichler, V., Pfaff, S., Weber, M., Kiesewetter, B., Hacker, M., Kazianka, L., Staber, P. B., Wester, H. J., Rohrbeck, J., Simonitsch-Klupp, I., & Haug, A. (2021). CXCR4 PET imaging of mantle cell lymphoma using [⁶⁸Ga]Pentixafor: Comparison with [¹⁸F]FDG-PET. Theranostics, 11(2), 567-578. https://doi.org/10.7150/thno.48620

Sauerzopf, U., Weidenauer, A., Dajic, I., Bauer, M., Bartova, L., Meyer, B., Nics, L., Philippe, C., Pfaff, S., Pichler, V., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Lanzenberger, R., Pezawas, L., Praschak-Rieder, N., & Willeit, M. (2021). Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical, 32, [102813]. https://doi.org/10.1016/j.nicl.2021.102813

Calabretta, R., Hoeller, C., Pichler, V., Mitterhauser, M., Karanikas, G., Haug, A., Li, X., & Hacker, M. (2020). Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries. Circulation, 142(24), 2396–2398. https://doi.org/10.1161/CIRCULATIONAHA.120.048708

Ozenil, M., Aronow, J., Piljak, D., Vraka, C., Holzer, W., Spreitzer, H., Wadsak, W., Hacker, M., & Pichler, V. (2020). Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1. Pharmaceuticals, 13(12), 1-12. [437]. https://doi.org/10.3390/ph13120437

Ozenil, M., Pacher, K., Balber, T., Vraka, C., Roller, A., Holzer, W., Spreitzer, H., Mitterhauser, M., Wadsak, W., Hacker, M., & Pichler, V. (2020). Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers. European Journal of Medicinal Chemistry, 204, [112623]. https://doi.org/10.1016/j.ejmech.2020.112623

Klebermass, E-M., Mahmudi, M., Miller, A., Pichler, V., Vraka, C., Balber, T., Haschemi, A., Wadsak, W., Hacker, M., Viernstein, H., & Mitterhauser, M. (2020). 2-[F-18]FDG metabolism: The role of alternative metabolic pathways. European Journal of Nuclear Medicine and Molecular Imaging, 47(Suppl 1), S12-S13. [OP-022]. https://doi.org/10.1007/s00259-020-04988-4

Mayerhoefer, M. E., Haug, A., Jäger, U., Pichler, V., Pfaff, S., Wester, H-J., Hacker, M., Kazianka, L., & Staber, P. B. (2020). In Human Visualization of Ibrutinib-Induced CLL Compartment Shift. Cancer immunology research, 8(8), 984-989. https://doi.org/10.1158/2326-6066.CIR-19-0880